logo
Plus   Neg
Share
Email

Sanofi : EU Okays Libtayo For Advanced Cutaneous Squamous Cell Carcinoma

Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNYNF,SNY) said that the European Commission granted conditional marketing authorization for Libtayo or cemiplimab to treat adults with metastatic or locally advanced cutaneous squamous cell carcinoma, who are not candidates for curative surgery or curative radiation.

Cutaneous squamous cell carcinoma is one of the most commonly diagnosed skin cancers worldwide, and and is especially difficult to treat in advanced stages.

Libtayo is being jointly developed by Sanofi and Regeneron under a global collaboration agreement. The recommended dose of Libtayo is 350 mg every 3 weeks administered by intravenous infusion over 30 minutes. Treatment may be continued until disease progression or unacceptable toxicity.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The National Labor Relations Board ruled in favor of McDonald's in a long-running case filed by workers who accused the fast-food giant of retaliation after they tried to unionize. The lawsuit, filed by 20 employees against McDonald's and some of its franchise operators in 2015. The lawsuit was seeking a ruling that would consider McDonald's a 'joint employer' with its franchisees. Shares of Facebook fell almost 3 percent in Thursday's trading after the Wall Street Journal reported that the Federal Trade Commission is considering seeking a preliminary injunction against Facebook amid antitrust concerns over the company's integration of its apps. Facebook had earlier said it was planning to integrate its three messaging services. Beverages giant Pepsi announced the launch Pepsi Café, a new coffee-infused cola, which will debut in the United States in April 2020. The new beverage, which aims to satisfy both cola lovers and coffee fanatics across the US, comes in two delicious flavors - Original and Vanilla, with roasted Arabica coffee. It will be available at all major national retailers beginning in April next year.
Follow RTT
>